SALT LAKE CITY, Jan. 4 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. announced today that Dr. Hunter Jackson, Chairman and CEO, and Dr. Anthony Coles, President and COO, will present a company update at the 24th JP Morgan Healthcare Conference in San Francisco, CA, at 10:30 a.m. PST on Thursday, January 12, 2006. The live event webcast may be accessed on the NPS site, www.npsp.com. A replay will be available within 24 hours after the presentation has concluded and may be accessed at the same link until midnight on February 12, 2006.
NPS discovers, develops and commercializes small molecules and recombinant proteins as drugs, primarily for the treatment of metabolic, bone and mineral, and central nervous system disorders. The company has one FDA approved product, one product candidate undergoing regulatory review for approval to market in the U.S. and Europe, as well as other drug candidates in various stages of clinical development backed by a strong discovery research effort. Additional information is available on the company's website, www.npsp.com.
NPS Pharmaceuticals, Inc.CONTACT: Brandi Simpson, Sr. Director, Investor Relations of NPSPharmaceuticals, Inc., +1-801-583-4939
Web site: http://www.npsp.com/
Company News On-Call: http://www.prnewswire.com/comp/613587.html /
